Free Trial

Bio-Techne (TECH) Competitors

Bio-Techne logo
$58.78 +0.31 (+0.53%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$58.96 +0.18 (+0.31%)
As of 07/25/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TECH vs. BRKR, A, CRL, DHR, IQV, MTD, RVTY, TMO, WAT, and ILMN

Should you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Bruker (BRKR), Agilent Technologies (A), Charles River Laboratories International (CRL), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Waters (WAT), and Illumina (ILMN).

Bio-Techne vs. Its Competitors

Bruker (NASDAQ:BRKR) and Bio-Techne (NASDAQ:TECH) are both mid-cap life sciences tools & services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Bruker presently has a consensus target price of $52.89, suggesting a potential upside of 26.11%. Bio-Techne has a consensus target price of $69.58, suggesting a potential upside of 18.38%. Given Bruker's higher possible upside, analysts clearly believe Bruker is more favorable than Bio-Techne.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bruker
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.40
Bio-Techne
0 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.62

In the previous week, Bruker had 14 more articles in the media than Bio-Techne. MarketBeat recorded 28 mentions for Bruker and 14 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 0.90 beat Bruker's score of 0.38 indicating that Bio-Techne is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bruker
8 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral
Bio-Techne
5 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

79.5% of Bruker shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 27.3% of Bruker shares are held by company insiders. Comparatively, 3.9% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Bio-Techne has lower revenue, but higher earnings than Bruker. Bio-Techne is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bruker$3.37B1.89$113.10M$0.5280.65
Bio-Techne$1.16B7.95$168.10M$0.8271.68

Bruker has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500.

Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.5%. Bruker pays out 38.5% of its earnings in the form of a dividend. Bio-Techne pays out 39.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Bio-Techne has a net margin of 10.89% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 19.47% beat Bio-Techne's return on equity.

Company Net Margins Return on Equity Return on Assets
Bruker2.31% 19.47% 5.95%
Bio-Techne 10.89%13.17%10.17%

Summary

Bio-Techne beats Bruker on 12 of the 19 factors compared between the two stocks.

Get Bio-Techne News Delivered to You Automatically

Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TECH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TECH vs. The Competition

MetricBio-TechneMED IndustryMedical SectorNASDAQ Exchange
Market Cap$9.17B$3.06B$5.69B$9.50B
Dividend Yield0.55%2.37%4.58%4.01%
P/E Ratio71.6821.1828.1020.05
Price / Sales7.95288.50432.4490.07
Price / Cash25.2742.7636.2258.56
Price / Book4.488.378.665.87
Net Income$168.10M-$55.19M$3.25B$258.55M
7 Day Performance13.00%5.88%4.23%3.74%
1 Month Performance11.33%17.33%10.52%11.75%
1 Year Performance-27.07%4.42%34.41%18.03%

Bio-Techne Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TECH
Bio-Techne
4.6739 of 5 stars
$58.78
+0.5%
$69.58
+18.4%
-25.3%$9.17B$1.16B71.683,100Analyst Upgrade
BRKR
Bruker
4.9669 of 5 stars
$35.63
-12.1%
$52.89
+48.4%
-34.7%$5.40B$3.37B68.5211,396High Trading Volume
A
Agilent Technologies
4.8688 of 5 stars
$112.12
-1.6%
$139.77
+24.7%
-11.0%$31.85B$6.51B27.6817,900Positive News
CRL
Charles River Laboratories International
4.4603 of 5 stars
$149.70
-3.1%
$174.54
+16.6%
-20.3%$7.35B$4.05B-230.3120,100Positive News
DHR
Danaher
4.8289 of 5 stars
$188.23
-1.0%
$248.48
+32.0%
-23.9%$134.71B$23.88B36.5563,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
IQV
IQVIA
4.5674 of 5 stars
$159.06
-1.0%
$222.45
+39.9%
-14.3%$27.52B$15.41B21.6788,000Trending News
Earnings Report
Analyst Forecast
Insider Trade
Analyst Revision
MTD
Mettler-Toledo International
4.1453 of 5 stars
$1,168.60
-2.2%
$1,280.90
+9.6%
-10.4%$24.28B$3.87B29.1417,300Positive News
Upcoming Earnings
RVTY
Revvity
2.9445 of 5 stars
$90.90
-2.5%
$123.07
+35.4%
-8.0%$10.71B$2.76B38.6811,000News Coverage
Upcoming Earnings
Dividend Announcement
Analyst Upgrade
TMO
Thermo Fisher Scientific
4.954 of 5 stars
$405.15
-2.3%
$599.30
+47.9%
-19.5%$152.94B$42.88B23.76125,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
WAT
Waters
4.7942 of 5 stars
$282.01
-1.9%
$381.94
+35.4%
-2.5%$16.78B$2.96B25.597,600Trending News
Analyst Downgrade
High Trading Volume
ILMN
Illumina
4.6269 of 5 stars
$94.79
-1.4%
$125.11
+32.0%
-6.8%$15.01B$4.37B-15.629,030Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:TECH) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners